US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist

11.620
-0.260-2.19%

Trading Jul 17 12:48 ET

1.85BMarket Cap-7289P/E (TTM)

Neumora Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

53.38%60.07M

85.54%252.1M

271.13%114M

85.82%56.86M

34.32%42.06M

-9.41%39.17M

-42.75%135.87M

15.71%30.72M

-82.82%30.6M

82.06%31.31M

Selling and administrative expenses

47.86%14.32M

46.12%45.48M

56.16%11.24M

89.53%15.26M

19.36%9.29M

19.74%9.68M

26.78%31.12M

-5.80%7.2M

20.90%8.05M

23.47%7.79M

-General and administrative expense

47.86%14.32M

46.12%45.48M

56.16%11.24M

89.53%15.26M

19.36%9.29M

19.74%9.68M

26.78%31.12M

-5.80%7.2M

20.90%8.05M

23.47%7.79M

Research and development costs

55.19%45.76M

97.26%206.62M

336.88%102.77M

84.49%41.6M

39.28%32.77M

-16.11%29.49M

-50.77%104.75M

24.40%23.52M

-86.85%22.55M

115.97%23.53M

Operating profit

-53.38%-60.07M

-85.54%-252.1M

-271.13%-114M

-85.82%-56.86M

-34.32%-42.06M

9.41%-39.17M

42.75%-135.87M

-15.71%-30.72M

82.82%-30.6M

-82.06%-31.31M

Net non-operating interest income expense

78.34%6.37M

264.20%16.61M

147.09%5.65M

172.97%3.84M

353.83%3.56M

4,050.00%3.57M

4.56M

2.29M

1.41M

784K

Non-operating interest income

78.34%6.37M

264.20%16.61M

147.09%5.65M

172.97%3.84M

353.83%3.56M

4,050.00%3.57M

--4.56M

--2.29M

--1.41M

--784K

Other net income (expense)

53.85%-12K

-141.98%-170K

-136.24%-104K

99.32%-1K

-124.68%-39K

-124.07%-26K

3,581.82%405K

168.01%287K

-243.69%-148K

-16.40%158K

Other non- operating income (expenses)

53.85%-12K

-141.98%-170K

-136.24%-104K

99.32%-1K

-124.68%-39K

-124.07%-26K

3,581.82%405K

168.01%287K

-243.69%-148K

-16.40%158K

Income before tax

-50.80%-53.72M

-80.02%-235.66M

-285.35%-108.46M

-80.71%-53.03M

-26.90%-38.54M

17.23%-35.63M

44.84%-130.9M

-4.36%-28.15M

83.52%-29.34M

-78.54%-30.37M

Income tax

268K

Net income

-50.80%-53.72M

-80.23%-235.93M

-286.31%-108.73M

-80.71%-53.03M

-26.90%-38.54M

17.23%-35.63M

44.84%-130.9M

-4.36%-28.15M

83.52%-29.34M

-78.54%-30.37M

Net income continuous Operations

-50.80%-53.72M

-80.23%-235.93M

-286.31%-108.73M

-80.71%-53.03M

-26.90%-38.54M

17.23%-35.63M

44.84%-130.9M

-4.36%-28.15M

83.52%-29.34M

-78.54%-30.37M

Minority interest income

Net income attributable to the parent company

-50.80%-53.72M

-80.23%-235.93M

-286.31%-108.73M

-80.71%-53.03M

-26.90%-38.54M

17.23%-35.63M

44.84%-130.9M

-4.36%-28.15M

83.52%-29.34M

-78.54%-30.37M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-50.80%-53.72M

-80.23%-235.93M

-286.31%-108.73M

-80.71%-53.03M

-26.90%-38.54M

17.23%-35.63M

44.84%-130.9M

-4.36%-28.15M

83.52%-29.34M

-78.54%-30.37M

Basic earnings per share

-45.02%-0.34

24.53%-3.63

-269.57%-0.6846

-490.32%-1.14

-26.90%-0.2537

17.23%-0.2345

-207.98%-4.81

-4.36%-0.1852

83.52%-0.1931

-78.54%-0.1999

Diluted earnings per share

-45.02%-0.34

24.53%-3.63

-269.57%-0.6846

-490.32%-1.14

-26.90%-0.2537

17.23%-0.2345

-207.98%-4.81

-4.36%-0.1852

83.52%-0.1931

-78.54%-0.1999

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	53.38%60.07M	85.54%252.1M	271.13%114M	85.82%56.86M	34.32%42.06M	-9.41%39.17M	-42.75%135.87M	15.71%30.72M	-82.82%30.6M	82.06%31.31M
Selling and administrative expenses	47.86%14.32M	46.12%45.48M	56.16%11.24M	89.53%15.26M	19.36%9.29M	19.74%9.68M	26.78%31.12M	-5.80%7.2M	20.90%8.05M	23.47%7.79M
-General and administrative expense	47.86%14.32M	46.12%45.48M	56.16%11.24M	89.53%15.26M	19.36%9.29M	19.74%9.68M	26.78%31.12M	-5.80%7.2M	20.90%8.05M	23.47%7.79M
Research and development costs	55.19%45.76M	97.26%206.62M	336.88%102.77M	84.49%41.6M	39.28%32.77M	-16.11%29.49M	-50.77%104.75M	24.40%23.52M	-86.85%22.55M	115.97%23.53M
Operating profit	-53.38%-60.07M	-85.54%-252.1M	-271.13%-114M	-85.82%-56.86M	-34.32%-42.06M	9.41%-39.17M	42.75%-135.87M	-15.71%-30.72M	82.82%-30.6M	-82.06%-31.31M
Net non-operating interest income expense	78.34%6.37M	264.20%16.61M	147.09%5.65M	172.97%3.84M	353.83%3.56M	4,050.00%3.57M	4.56M	2.29M	1.41M	784K
Non-operating interest income	78.34%6.37M	264.20%16.61M	147.09%5.65M	172.97%3.84M	353.83%3.56M	4,050.00%3.57M	--4.56M	--2.29M	--1.41M	--784K
Other net income (expense)	53.85%-12K	-141.98%-170K	-136.24%-104K	99.32%-1K	-124.68%-39K	-124.07%-26K	3,581.82%405K	168.01%287K	-243.69%-148K	-16.40%158K
Other non- operating income (expenses)	53.85%-12K	-141.98%-170K	-136.24%-104K	99.32%-1K	-124.68%-39K	-124.07%-26K	3,581.82%405K	168.01%287K	-243.69%-148K	-16.40%158K
Income before tax	-50.80%-53.72M	-80.02%-235.66M	-285.35%-108.46M	-80.71%-53.03M	-26.90%-38.54M	17.23%-35.63M	44.84%-130.9M	-4.36%-28.15M	83.52%-29.34M	-78.54%-30.37M
Income tax		268K					0
Net income	-50.80%-53.72M	-80.23%-235.93M	-286.31%-108.73M	-80.71%-53.03M	-26.90%-38.54M	17.23%-35.63M	44.84%-130.9M	-4.36%-28.15M	83.52%-29.34M	-78.54%-30.37M
Net income continuous Operations	-50.80%-53.72M	-80.23%-235.93M	-286.31%-108.73M	-80.71%-53.03M	-26.90%-38.54M	17.23%-35.63M	44.84%-130.9M	-4.36%-28.15M	83.52%-29.34M	-78.54%-30.37M
Minority interest income
Net income attributable to the parent company	-50.80%-53.72M	-80.23%-235.93M	-286.31%-108.73M	-80.71%-53.03M	-26.90%-38.54M	17.23%-35.63M	44.84%-130.9M	-4.36%-28.15M	83.52%-29.34M	-78.54%-30.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-50.80%-53.72M	-80.23%-235.93M	-286.31%-108.73M	-80.71%-53.03M	-26.90%-38.54M	17.23%-35.63M	44.84%-130.9M	-4.36%-28.15M	83.52%-29.34M	-78.54%-30.37M
Basic earnings per share	-45.02%-0.34	24.53%-3.63	-269.57%-0.6846	-490.32%-1.14	-26.90%-0.2537	17.23%-0.2345	-207.98%-4.81	-4.36%-0.1852	83.52%-0.1931	-78.54%-0.1999
Diluted earnings per share	-45.02%-0.34	24.53%-3.63	-269.57%-0.6846	-490.32%-1.14	-26.90%-0.2537	17.23%-0.2345	-207.98%-4.81	-4.36%-0.1852	83.52%-0.1931	-78.54%-0.1999
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall